Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacist-Led Deprescribing of Azithromycin in Respiratory Tract Infections
NCT07849491Enrolling by invitation
- Sponsor
- Xi'an Jiaotong University
- Start
- May 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in respiratory tract infection (RTI) (2 arms), sponsored by Xi'an Jiaotong University. Primary endpoints: Optimal Azithromycin Use, Clinical Cure Rate and 1 more. Started May 2026; status: enrolling by invitation.
02
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT07849491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07849491.